Novosteo Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
18
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$16.5M
- Investors
-
1
Novosteo General Information
Description
Developer of a drug discovery platform designed to reduce the morbidity, mortality, and loss of productivity associated with bone fractures. The company's platform includes a series of fracture-targeted drugs that concentrate a drug's healing power specifically at the fracture site, thereby accelerating and improving the healing process, enabling patients to reduce the debilitating and often life-threatening effects of bone fractures.
Contact Information
Website
www.novosteo.comCorporate Office
- 1281 Win Hentschel Boulevard
- Suite 1594
- West Lafayette, IN 47906
- United States
Corporate Office
- 1281 Win Hentschel Boulevard
- Suite 1594
- West Lafayette, IN 47906
- United States
Novosteo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 19-May-2022 | $16.5M | Completed | Pre-Clinical Trials | ||
| 7. Early Stage VC (Series A) | 29-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 15-Sep-2019 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 08-Aug-2019 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 08-May-2019 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 26-Dec-2018 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 09-Oct-2018 | $1.71M | Completed | Pre-Clinical Trials | ||
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Novosteo Comparisons
Industry
Financing
Details
Novosteo Competitors (16)
One of Novosteo’s 16 competitors is Synartro, a Venture Capital-Backed company based in Stockholm, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synartro | Venture Capital-Backed | Stockholm, Sweden | ||||
| NOVADIP | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | ||||
| Bonesupport | Formerly PE-Backed | Lund, Sweden | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| Arvinas | Formerly VC-backed | New Haven, CT |
Novosteo Signals
Novosteo Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioCrossroads | Venture Capital | Minority | ||
| Elevate Ventures | Venture Capital | Minority | ||
| Kairos Ventures | Venture Capital | Minority | ||
| National Institute of Dental and Craniofacial Research | Government | |||
| National Institutes of Health | Government |
Novosteo FAQs
-
When was Novosteo founded?
Novosteo was founded in 2017.
-
Where is Novosteo headquartered?
Novosteo is headquartered in West Lafayette, IN.
-
What is the size of Novosteo?
Novosteo has 18 total employees.
-
What industry is Novosteo in?
Novosteo’s primary industry is Pharmaceuticals.
-
Is Novosteo a private or public company?
Novosteo is a Private company.
-
What is the current valuation of Novosteo?
The current valuation of Novosteo is .
-
What is Novosteo’s current revenue?
The current revenue for Novosteo is .
-
How much funding has Novosteo raised over time?
Novosteo has raised $18.5M.
-
Who are Novosteo’s investors?
BioCrossroads, Elevate Ventures, Kairos Ventures, National Institute of Dental and Craniofacial Research, and National Institutes of Health are 5 of 9 investors who have invested in Novosteo.
-
Who are Novosteo’s competitors?
Synartro, NOVADIP, Bonesupport, Dicerna Pharmaceuticals, and Arvinas are some of the 16 competitors of Novosteo.
-
When was Novosteo acquired?
Novosteo was acquired on 19-May-2022.
-
Who acquired Novosteo?
Novosteo was acquired by IRulya Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process